McKracken,
The median survival benefit of Provenge has been understated as some on the control group who relapsed were given frozen Provenge.
Taking this into account, the median was over 7months.
http://seekingalpha.com/article/332382-provenge-is-probably-more-effective-than-we-think
(Median survival means 50% of patients will live longer than the stated time, some significantly longer.)
food for thought, page-42
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $479.3M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.5¢ | 32.0¢ | $772.1K | 2.365M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 343027 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 87817 | 10 |
View Market Depth
| Last trade - 13.05pm 25/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |